Literature DB >> 6425354

Modification of interpretive breakpoints for netilmicin disk susceptibility tests with Pseudomonas aeruginosa.

A L Barry, G H Miller, R S Hare, R N Jones, C Thornsberry.   

Abstract

Regression analysis of data correlating 30-micrograms netilmicin disk zone diameters with microdilution MICs, obtained by testing close-interval dilution steps, was performed with 77 selected strains of Pseudomonas aeruginosa, each tested in three independent laboratories. A zone of greater than or equal to 15 mm correlated with an MIC of less than or equal to 12 micrograms/ml (susceptible), and a zone of less than or equal to 12 mm correlated with an MIC of greater than 16 micrograms/ml (resistant). Additional disk tests were performed with 256 strains having known resistance mechanisms and 280 susceptible strains: the majority were appropriately categorized by these interpretive zone standards. The previously recommended standards of greater than or equal to 17 mm (MIC, less than or equal to 8.0 micrograms/ml) for the susceptible category inappropriately placed a significant number of truly susceptible P. aeruginosa strains in the intermediate category.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6425354      PMCID: PMC271054          DOI: 10.1128/jcm.19.3.311-314.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  9 in total

1.  Pharmacokinetic study of netilmicin.

Authors:  B R Meyers; S Z Hirschman; G Wormser; D Siegel
Journal:  Antimicrob Agents Chemother       Date:  1977-07       Impact factor: 5.191

2.  Tentative interpretive criteria for the diffusion susceptibility test using 30-microgram netilmicin disks.

Authors:  R N Jones; A L Barry; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1980-09       Impact factor: 5.191

3.  Pharmacology and efficacy of netilmicin.

Authors:  I Trestman; J Parsons; J Santoro; G Goodhart; D Kaye
Journal:  Antimicrob Agents Chemother       Date:  1978-05       Impact factor: 5.191

4.  Pharmacokinetic properties of netilmicin in newborn infants.

Authors:  J D Siegel; G H McCracken; M L Thomas; N Threlkeld
Journal:  Antimicrob Agents Chemother       Date:  1979-02       Impact factor: 5.191

5.  Randomised, controlled trial of the comparative efficacy, auditory toxicity, and nephrotoxicity of tobramycin and netilmicin.

Authors:  A M Lerner; M P Reyes; L A Cone; D C Blair; W Jansen; G E Wright; R R Lorber
Journal:  Lancet       Date:  1983-05-21       Impact factor: 79.321

6.  Gentamicin and amikacin disk susceptibility tests with Pseudomonas aeruginosa: definition of minimal inhibitory concentration correlates for susceptible and resistant categories.

Authors:  A L Barry; C Thornsberry; R N Jones
Journal:  J Clin Microbiol       Date:  1981-05       Impact factor: 5.948

7.  Gentamicin, tobramycin, and sisomicin disc susceptibility tests. Revised zone standards for interpretation.

Authors:  A L Barry; C Thornsberry; R N Jones; E H Gerlach
Journal:  Am J Clin Pathol       Date:  1981-04       Impact factor: 2.493

8.  Azlocillin, a ureido penicillin active against Pseudomonas aeruginosa: interpretive zone standards and quality control parameters for tests with 75-mu g disks.

Authors:  A L Barry; R N Jones; C Thornsberry; T L Gavan
Journal:  J Clin Microbiol       Date:  1982-07       Impact factor: 5.948

9.  Cefsulodin: antibacterial activity and tentative interpretive zone standards for the disk susceptibility test.

Authors:  A L Barry; R N Jones; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1981-10       Impact factor: 5.191

  9 in total
  4 in total

1.  Laboratory- and species-specific interpretive breakpoints for disk diffusion tests of chloramphenicol susceptibility of Haemophilus influenzae.

Authors:  G Kronvall; S Ringertz; I Karlsson; E Göransson; K Dornbusch
Journal:  Antimicrob Agents Chemother       Date:  1988-10       Impact factor: 5.191

2.  Netilmicin disk susceptibility tests: effect of cations on the MIC correlates.

Authors:  A L Barry; G H Miller; R S Hare; C Thornsberry; R N Jones
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

3.  Evaluation of Aminoglycoside and Carbapenem Resistance in a Collection of Drug-Resistant Pseudomonas aeruginosa Clinical Isolates.

Authors:  Selina Y L Holbrook; Sylvie Garneau-Tsodikova
Journal:  Microb Drug Resist       Date:  2017-12-20       Impact factor: 3.431

4.  Influence of cation supplements on activity of netilmicin against Pseudomonas aeruginosa in vitro and in vivo.

Authors:  A L Barry; G H Miller; C Thornsberry; R S Hare; R N Jones; R R Lorber; R Ferraresi; C Cramer
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.